KAYLIE ZIMMERMAN: Open Payments
NPI 1790207207 · HOLTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 18 payments from 11 companies in 2025. Trend: 2023 $110 · 2024 $185 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $80 |
| Abbott Laboratories | 3 | $68 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| Amgen Inc. | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
| Viatris Specialty LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: LEQVIO, FREESTYLE LIBRE 3, Qelbree, Wegovy, UBRELVY, YUPELRI, Cologuard Collection Kit, EVENITY.
Industry payments across KS — which companies pay providers there.
